Alexis Turgeon first graduated from Université Laval medical school in 1999 and, following residency training in Anesthesiology, he completed a master’s degree in Clinical Epidemiology. He pursued training in Critical Care Medicine at the University of Ottawa along with a research fellowship at the Clinical Epidemiology Unit of the Ottawa Hospital Research Institute. He is an Associate Professor and Director of Research in the Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, at Université Laval. He is a scientist and the Deputy Director of the Population Health and Optimal Health Practices Unit of the CHU de Québec – Université Laval Research Center. He practices Critical Care Medicine and Anesthesiology at the CHU de Québec – Université Laval (Hôpital de l’Enfant-Jésus) in Québec City.
He leads a successful research program, funded by the Canadian Institutes of Health Research (CIHR), on the determination of prognosis (TBI-Prognosis Study) and on the comprehension of level of care decisions in neurocritically ill patients (TBI-QualE study). He also has developed a comprehensive program of research on blood transfusion in traumatic brain injury, and on the use of blood products in critically ill patients. He leads the TSiTBI trial, a $1,139,105 CIHR-funded multicenter randomized clinical trial that will determine the optimal blood cell transfusion threshold for victims of moderate to severe traumatic brain injury (co-PIs F Lauzier, D Fergusson). Dr Turgeon recently obtained a CIHR Foundation Scheme grant ($1,947,960) on Optimal Practices in Critical Care Neurology and Trauma.
Dr. Turgeon is the co-chair of the Canadian Traumatic brain injury Research Consortium, the Scientific Director of Cochrane Canada – Francophone and is an active member of the Canadian Critical Care Trials Group. He is the recipient of the new Canada Research Chair in Critical Care Neurology and Trauma.